Differences in Patients' Perceptions of Schizophrenia Between Māori and New Zealand Europeans

Sanders, Deanna; Kydd, Robert R.; Morunga, Eva; Broadbent, Elizabeth

doi:10.3109/00048674.2011.561479

Cited by 20 publications

(13 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our results are also consistent with the results of three recent studies on the importance of psychosocial causal beliefs and their link with better clinical outcomes (Sanders et al 2011; Lüllmann et al 2011; Freeman et al 2012). Our study suggests that integrating psychosocial and biological aspects within a causal model in psychosocial intervention programs may be more efficacious than focusing only on the biological model, and basing treatment only on prescribing of antipsychotic drugs.…”

Section: Discussionsupporting

confidence: 92%

“…However, medications alone are not sufficient for recovery in schizophrenia, and psychosocial treatments are a necessary complement (Kern et al, 2009). Three recent studies suggested that a psychosocial causal model could be relevant for treatment success by promoting non-pharmacological treatment (Sanders, et al, 2011; Lüllmann et al, 2011; Freeman et al, 2012). Causal beliefs may also act in divergent ways across the spectrum of treatment.…”

Section: Introductionmentioning

confidence: 99%

“…Second, findings about patient and caregiver beliefs as a determinant of clinical outcomes draw on a separate literature, and should now be studied together. Finally, there is cultural variability in the beliefs about the causes of schizophrenia between countries as well as their relationships with clinical outcomes (Saravanan et al, 2007; Zafar et al, 2008; Sanders et al, 2011). Previous findings should thus be extended to Latin American countries where no published studies have investigated this issue.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

The relationships between patients’ and caregivers’ beliefs about the causes of schizophrenia and clinical outcomes in Latin American countries

Caqueo-Urízar

Boyer

Baumstarck

et al. 2015

Psychiatry Research

View full text Add to dashboard Cite

Beliefs about the causes of schizophrenia are thought to impact treatment outcomes. We investigated 3 theoretically opposing belief systems (biological, psychosocial, magical-religious) in relation to the severity of positive and negative symptoms and to attitudes towards medications. We recruited 253 patients with schizophrenia and their primary caregivers from public mental health clinics in Bolivia, Chile, and Peru. We assessed patients’ and caregivers’ beliefs about the causes of schizophrenia, which were used as predictors of symptom severity and medication attitudes in linear regression analyses. Patients’ scores on biological, psychosocial, and magical-religious beliefs were positively correlated with one another, indicating that these domains were not, as anticipated, “opposing.” Patients with higher levels of biological and psychosocial beliefs had significantly lower levels of positive and negative symptoms; in contrast, higher levels of magical-religious beliefs were associated with increased positive symptoms and less favorable attitudes towards medications. Patients’ belief systems are significant predictors of symptom severity and medication attitudes. Research is needed on the extent to which psychotherapeutic treatments for schizophrenia should bolster patients’ beliefs in the biological and psychosocial domains and weaken beliefs in the magical-religious domain; this research should also attend to the ethical considerations involved in intervening on belief systems cross-culturally.

show abstract

Section: Discussionsupporting

confidence: 92%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

The relationships between patients’ and caregivers’ beliefs about the causes of schizophrenia and clinical outcomes in Latin American countries

Caqueo-Urízar

Boyer

Baumstarck

et al. 2015

Psychiatry Research

View full text Add to dashboard Cite

show abstract

“…Cameron Lacey 1,2,3 To the Editor We read with interest the paper by Sanders and colleagues (Sanders et al, 2011) investigating the perceptions of schizophrenia among Maori and non-Maori. It is pleasing to see research that attempts to give voice to the experience and views of tangata whaiora regarding their illnesses and future.…”

Section: Re: Sanders Et Al (2011) Differences In Patients' Perceptiomentioning

confidence: 87%

Quetiapine-related harms are on the rise

Heilbronn

Lloyd

McElwee

et al. 2012

Aust N Z J Psychiatry

View full text Add to dashboard Cite

“…Research on Māori and Pakeha (European) people being treated for schizophrenia within clinical services did not demonstrate a difference in attitude towards medication (Sanders et al, 2011). Being aware of the importance of Māori culture should not come with assumptions that Māori will be necessarily opposed to or not interested in information about schizophrenia as a medical condition and the effective treatments available.…”

Section: Schizophrenia In Māorimentioning

confidence: 99%

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders

Galletly

Castle

Dark

et al. 2016

Aust N Z J Psychiatry

665

672

View full text Add to dashboard Cite

Objectives: This guideline provides recommendations for the clinical management of schizophrenia and related disorders for health professionals working in Australia and New Zealand. It aims to encourage all clinicians to adopt best practice principles. The recommendations represent the consensus of a group of Australian and New Zealand experts in the management of schizophrenia and related disorders. This guideline includes the management of ultra-high risk syndromes, first-episode psychoses and prolonged psychoses, including psychoses associated with substance use. It takes a holistic approach, addressing all aspects of the care of people with schizophrenia and related disorders, not only correct diagnosis and symptom relief but also optimal recovery of social function. Methods:The writing group planned the scope and individual members drafted sections according to their area of interest and expertise, with reference to existing systematic reviews and informal literature reviews undertaken for this guideline. In addition, experts in specific areas contributed to the relevant sections. All members of the writing group reviewed the entire document. The writing group also considered relevant international clinical practice guidelines. Evidence-based recommendations were formulated when the writing group judged that there was sufficient evidence on a topic. Where evidence was weak or lacking, consensus-based recommendations were formulated. Consensus-based recommendations are based on the consensus of a group of experts in the field and are informed by their agreement as a group, according to their collective clinical and research knowledge and experience. Key considerations were selected and reviewed by the writing group. To encourage wide community participation, the Royal Australian and New Zealand College of Psychiatrists invited review by its committees and members, an expert advisory committee and key stakeholders including professional bodies and special interest groups. RANZCP GuidelinesGalletly et al. 411 Australian & New Zealand Journal of Psychiatry, 50(5)Results: The clinical practice guideline for the management of schizophrenia and related disorders reflects an increasing emphasis on early intervention, physical health, psychosocial treatments, cultural considerations and improving vocational outcomes. The guideline uses a clinical staging model as a framework for recommendations regarding assessment, treatment and ongoing care. This guideline also refers its readers to selected published guidelines or statements directly relevant to Australian and New Zealand practice. Conclusions:This clinical practice guideline for the management of schizophrenia and related disorders aims to improve care for people with these disorders living in Australia and New Zealand. It advocates a respectful, collaborative approach; optimal evidence-based treatment; and consideration of the specific needs of those in adverse circumstances or facing additional challenges.

show abstract

Differences in Patients' Perceptions of Schizophrenia Between Māori and New Zealand Europeans

Cited by 20 publications

References 21 publications

The relationships between patients’ and caregivers’ beliefs about the causes of schizophrenia and clinical outcomes in Latin American countries

The relationships between patients’ and caregivers’ beliefs about the causes of schizophrenia and clinical outcomes in Latin American countries

Quetiapine-related harms are on the rise

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders

Contact Info

Product

Resources

About